Back to search

Article

High Expression of SAMM50 Indicates Poor Clinical Prognosis in Hepatocellular Carcinoma and Represents a Potential Novel Biomarker

2026-05-13

Abstract excerpt

<title>Abstract</title> <p>Background Identifying diagnostic and prognostic biomarkers and therapeutic targets for hepatocellular carcinoma (HCC) is essential to improve risk stratification, guide individualized treatment, and enhance therapeutic efficacy. Methods The expression of SAMM50 was initially analyzed in publicly accessible curated genomic and proteomic databases, such as the Cancer Cell Line Encyclop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2513fe2-90dd-540a-9766-9d327c69679a
DOI
10.21203/rs.3.rs-9536726/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High Expression of SAMM50 Indicates Poor Clinical Prognosis in Hepatocellular Carcinoma and Represents a Potential Novel BiomarkerDOI 10.21203/rs.3.rs-9536726/v1
Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinoma.Semantic proximity
Impact of SETD8/KMT5A Overexpression on Hepatocellular Carcinoma Progression and PrognosisSemantic proximity
Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinomaSemantic proximity
Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.Semantic proximity
Oncogenic Function of Growth Arrest-specific Transcript 5 by Competing with miR-423-3p to Regulate SMARCA4 in Hepatocellular CarcinomaSemantic proximity
Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR ‐211‐5p/ CREB5 axisSemantic proximity
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.Semantic proximity
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinomaSemantic proximity
Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo.Semantic proximity
Super-Enhancer–Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular CarcinomaSemantic proximity
Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysisSemantic proximity
TMEM201 overexpression is associated with tumor progression and unfavorable prognosis in hepatocellular carcinomaSemantic proximity
Select a neighboring publication to make it the new centre.